2024-02-19 22:16:57 ET
Summary
- West Pharmaceutical Services has shown strong financial performance, with a total return of 652.5% in the last 10 years.
- In its most recent Q4 2023 results, the company put up relatively flat growth, and a continuation of the trend is expected in 2024.
- While the company benefits long-term from secular tailwinds, the valuation is far too expensive for a single-digit growth company, especially after a 51% rise in the share price in 2023.
Introduction
Read the full article on Seeking Alpha
For further details see:
West Pharmaceutical Services: Still Too Expensive After The Recent Drop